Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Cell Signal. 2013 Aug 29;25(12):10.1016/j.cellsig.2013.08.016. doi: 10.1016/j.cellsig.2013.08.016

Fig 5. Extracellular domain of LRP6 is cross-linked by TG2.

Fig 5

(A) TG2 activity assay performed using stable levels of TG2 and Ez-link pentylamine with increasing doses of LRP6 shows that LRP6 inhibits TG2 cross-linking activity. (B) Western blot analysis of LRP6ΔC alone (left panel) or an LRP6ΔC/TG2 mixture (right panel) reveals formation of LRP6 complexes in the presence of gpTG2. (C) Induction of β-catenin activity by TG2 can be blocked by treatment with a TG2-specific inhibitor, KCC009.